🟢 ProMIS Neurosciences is trading 11% up in pre-market with no confirmed catalyst

ProMIS Neurosciences is trading 10.6% higher at $12.00, versus its September 30 close of $10.85; no catalyst is confirmed for the pre-market move.

• A sharp rebound follows several down sessions.
• On September 30, ProMIS announced October conference participation, including H.C. Wainwright Biotech On Tap; no new clinical or financial results were reported.
• Broad indicators are positive, but supplied index moves below 0.5% do not establish a market-driven explanation.